Principal Financial Group Inc Dynavax Technologies Corp Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$10.05 - $11.61 $1.86 Million - $2.15 Million	-184,961 Reduced 24.25%	577,727 $6.44 Million
Q2 2024 Jul 29, 2024	SELL	$10.73 - $12.58 $56,021 - $65,680	-5,221 Reduced 0.68%	762,688 $8.56 Million
Q1 2024 Apr 29, 2024	BUY	$11.7 - $14.98 $362,723 - $464,409	31,002 Added 4.21%	767,909 $9.53 Million
Q4 2023 Feb 07, 2024	SELL	$13.09 - $14.98 $7,186 - $8,224	-549 Reduced 0.07%	736,907 $10.3 Million
Q3 2023 Nov 02, 2023	BUY	$12.64 - $14.99 $332,823 - $394,701	26,331 Added 3.7%	737,456 $10.9 Million
Q2 2023 Aug 07, 2023	SELL	$9.85 - $13.17 $442,156 - $591,188	-44,889 Reduced 5.94%	711,125 $9.19 Million
Q1 2023 May 09, 2023	SELL	$9.44 - $11.88 $230,354 - $289,895	-24,402 Reduced 3.13%	756,014 $7.42 Million
Q4 2022 Feb 09, 2023	SELL	$10.27 - $13.29 $52,500 - $67,938	-5,112 Reduced 0.65%	780,416 $8.3 Million
Q3 2022 Nov 09, 2022	SELL	$9.93 - $17.44 $781,262 - $1.37 Million	-78,677 Reduced 9.1%	785,528 $8.2 Million
Q2 2022 Aug 10, 2022	BUY	$7.45 - $12.83 $5.38 Million - $9.26 Million	721,936 Added 507.44%	864,205 $10.9 Million
Q1 2022 May 09, 2022	SELL	$9.75 - $14.44 $534,056 - $790,951	-54,775 Reduced 27.8%	142,269 $1.54 Million
Q4 2021 Feb 09, 2022	BUY	$13.17 - $20.94 $2 Million - $3.18 Million	151,934 Added 336.81%	197,044 $2.77 Million
Q3 2021 Nov 09, 2021	BUY	$9.16 - $19.83 $15,819 - $34,246	1,727 Added 3.98%	45,110 $866,000
Q2 2021 Aug 10, 2021	SELL	$7.25 - $10.99 $15,036 - $22,793	-2,074 Reduced 4.56%	43,383 $427,000
Q1 2021 May 10, 2021	SELL	$4.57 - $11.18 $6,448 - $15,774	-1,411 Reduced 3.01%	45,457 $447,000
Q4 2020 Feb 08, 2021	BUY	$3.73 - $5.6 $55,431 - $83,221	14,861 Added 46.43%	46,868 $209,000
Q3 2020 Nov 06, 2020	SELL	$4.32 - $11.7 $673 - $1,825	-156 Reduced 0.49%	32,007 $138,000
Q2 2020 Aug 05, 2020	BUY	$2.94 - $9.1 $58,603 - $181,390	19,933 Added 162.98%	32,163 $286,000
Q1 2020 May 12, 2020	SELL	$2.27 - $6.2 $24,386 - $66,606	-10,743 Reduced 46.76%	12,230 $43,000
Q4 2019 Feb 05, 2020	BUY	$3.46 - $6.93 $44,720 - $89,570	12,925 Added 128.63%	22,973 $131,000
Q3 2019 Nov 13, 2019	BUY	$2.69 - $4.85 $27,029 - $48,732	10,048 New	10,048 $36,000
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $92,218 - $150,449	-11,329 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $134,248 - $181,264	11,329 New	11,329 $140,000

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$279 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$159 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$117 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$106 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$97.8 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account